Clarivate Plc (CLVT)
After hours:
| Previous close | 10.79 |
| Open | 10.75 |
| Bid | 10.59 x 2200 |
| Ask | 11.41 x 4000 |
| Day's range | 10.75 - 11.09 |
| 52-week range | 7.85 - 17.91 |
| Volume | |
| Avg. volume | 7,289,403 |
| Market cap | 7.416B |
| Beta (5Y monthly) | 0.99 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.51 |
| Earnings date | 08 Mar 2023 - 13 Mar 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 11.95 |
- Zacks
How Much Upside is Left in Clarivate PLC (CLVT)? Wall Street Analysts Think 39.2%
The mean of analysts' price targets for Clarivate PLC (CLVT) points to a 39.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
- PR Newswire
Clarivate Identifies Fifteen Potential Blockbuster Drugs in Annual Drugs to Watch Report
Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced the release of its annual Drugs to Watch™ report. In its 10th year, the Drugs to Watch report provides in-depth predictive analysis of drugs with the potential to transform treatment paradigms and serve unmet patient needs. The report serves as a key industry resource in an ever-evolving drug innovation landscape - with more than 70 drugs having been iden
- PR Newswire
Clarivate and the Chinese Academy of Sciences Release Annual Joint Report to Identify 165 Research Fronts
Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, and the Chinese Academy of Sciences (CAS) today released Research Fronts 2022, their ninth annual collaborative report. The report identifies significant areas in the world of sciences and social sciences as to where the scientific community is focusing its attention, including several COVID-related fronts and areas mirrored by the research fields of Noble Prize in rece
